These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 15380536)
1. A perforin/granzyme-positive MDS-derived T cell line, K2-MDS, induces apoptosis in CD34+ cells through the fractalkine-CX3CR1 system. Morita Y; Matsuda M; Hanamoto H; Shimada T; Tatsumi Y; Maeda Y; Kanamaru A Clin Immunol; 2004 Oct; 113(1):109-16. PubMed ID: 15380536 [TBL] [Abstract][Full Text] [Related]
2. Involvement of interaction between Fractalkine and CX3CR1 in cytotoxicity of natural killer cells against tumor cells. Zhang X; Wei H; Wang H; Tian Z Oncol Rep; 2006 Feb; 15(2):485-8. PubMed ID: 16391873 [TBL] [Abstract][Full Text] [Related]
3. Smooth muscle cells in human atherosclerotic plaques express the fractalkine receptor CX3CR1 and undergo chemotaxis to the CX3C chemokine fractalkine (CX3CL1). Lucas AD; Bursill C; Guzik TJ; Sadowski J; Channon KM; Greaves DR Circulation; 2003 Nov; 108(20):2498-504. PubMed ID: 14581400 [TBL] [Abstract][Full Text] [Related]
4. The high expression of Fractalkine results in a better prognosis for colorectal cancer patients. Ohta M; Tanaka F; Yamaguchi H; Sadanaga N; Inoue H; Mori M Int J Oncol; 2005 Jan; 26(1):41-7. PubMed ID: 15586223 [TBL] [Abstract][Full Text] [Related]
5. Fractalkine in vascular biology: from basic research to clinical disease. Umehara H; Bloom ET; Okazaki T; Nagano Y; Yoshie O; Imai T Arterioscler Thromb Vasc Biol; 2004 Jan; 24(1):34-40. PubMed ID: 12969992 [TBL] [Abstract][Full Text] [Related]
6. Antitumor immune response by CX3CL1 fractalkine gene transfer depends on both NK and T cells. Xin H; Kikuchi T; Andarini S; Ohkouchi S; Suzuki T; Nukiwa T; Huqun ; Hagiwara K; Honjo T; Saijo Y Eur J Immunol; 2005 May; 35(5):1371-80. PubMed ID: 15789339 [TBL] [Abstract][Full Text] [Related]
7. Chemokine fractalkine mediates leukocyte recruitment to inflammatory endothelial cells in flowing whole blood: a critical role for P-selectin expressed on activated platelets. Schulz C; Schäfer A; Stolla M; Kerstan S; Lorenz M; von Brühl ML; Schiemann M; Bauersachs J; Gloe T; Busch DH; Gawaz M; Massberg S Circulation; 2007 Aug; 116(7):764-73. PubMed ID: 17679613 [TBL] [Abstract][Full Text] [Related]
8. Fractalkine-CX3CR1 axis regulates tumor cell cycle and deteriorates prognosis after radical resection for hepatocellular carcinoma. Matsubara T; Ono T; Yamanoi A; Tachibana M; Nagasue N J Surg Oncol; 2007 Mar; 95(3):241-9. PubMed ID: 17323338 [TBL] [Abstract][Full Text] [Related]
9. Migration of CX3CR1-positive T cells producing type 1 cytokines and cytotoxic molecules into the synovium of patients with rheumatoid arthritis. Nanki T; Imai T; Nagasaka K; Urasaki Y; Nonomura Y; Taniguchi K; Hayashida K; Hasegawa J; Yoshie O; Miyasaka N Arthritis Rheum; 2002 Nov; 46(11):2878-83. PubMed ID: 12428227 [TBL] [Abstract][Full Text] [Related]
10. The involvement of the fractalkine receptor in the transmigration of neuroblastoma cells through bone-marrow endothelial cells. Nevo I; Sagi-Assif O; Meshel T; Ben-Baruch A; Jöhrer K; Greil R; Trejo LE; Kharenko O; Feinmesser M; Yron I; Witz IP Cancer Lett; 2009 Jan; 273(1):127-39. PubMed ID: 18778890 [TBL] [Abstract][Full Text] [Related]
11. Viral macrophage inflammatory protein-II and fractalkine (CX3CL1) chimeras identify molecular determinants of affinity, efficacy, and selectivity at CX3CR1. Davis CN; Zujovic V; Harrison JK Mol Pharmacol; 2004 Dec; 66(6):1431-9. PubMed ID: 15361546 [TBL] [Abstract][Full Text] [Related]
12. Characterisation of fractalkine/CX3CL1 and fractalkine receptor (CX3CR1) expression in abdominal aortic aneurysm disease. Patel A; Jagadesham VP; Porter KE; Scott DJ; Carding SR Eur J Vasc Endovasc Surg; 2008 Jul; 36(1):20-7. PubMed ID: 18296082 [TBL] [Abstract][Full Text] [Related]
13. Expression of CX3C chemokine, fractalkine, and its receptor CX3CR1 in experimental autoimmune anterior uveitis. Fang IM; Lin CP; Yang CM; Chen MS; Yang CH Mol Vis; 2005 Jul; 11():443-51. PubMed ID: 16030495 [TBL] [Abstract][Full Text] [Related]
14. Fractalkine (CX3CL1) and fractalkine receptor (CX3CR1) distribution in spinal cord and dorsal root ganglia under basal and neuropathic pain conditions. Verge GM; Milligan ED; Maier SF; Watkins LR; Naeve GS; Foster AC Eur J Neurosci; 2004 Sep; 20(5):1150-60. PubMed ID: 15341587 [TBL] [Abstract][Full Text] [Related]
15. Fractalkine and CX3CR1 are involved in the recruitment of intraepithelial lymphocytes of intrahepatic bile ducts. Isse K; Harada K; Zen Y; Kamihira T; Shimoda S; Harada M; Nakanuma Y Hepatology; 2005 Mar; 41(3):506-16. PubMed ID: 15726664 [TBL] [Abstract][Full Text] [Related]
16. The chemokines, CX3CL1, CCL14, and CCL4, promote human trophoblast migration at the feto-maternal interface. Hannan NJ; Jones RL; White CA; Salamonsen LA Biol Reprod; 2006 May; 74(5):896-904. PubMed ID: 16452465 [TBL] [Abstract][Full Text] [Related]
17. Membrane-bound form of fractalkine induces IFN-gamma production by NK cells. Yoneda O; Imai T; Nishimura M; Miyaji M; Mimori T; Okazaki T; Domae N; Fujimoto H; Minami Y; Kono T; Bloom ET; Umehara H Eur J Immunol; 2003 Jan; 33(1):53-8. PubMed ID: 12594832 [TBL] [Abstract][Full Text] [Related]
18. Fractalkine receptor expression by T lymphocyte subpopulations and in vivo production of fractalkine in human. Foussat A; Coulomb-L'Hermine A; Gosling J; Krzysiek R; Durand-Gasselin I; Schall T; Balian A; Richard Y; Galanaud P; Emilie D Eur J Immunol; 2000 Jan; 30(1):87-97. PubMed ID: 10602030 [TBL] [Abstract][Full Text] [Related]
19. Fractalkine mediates natural killer-dependent antitumor responses in vivo. Lavergne E; Combadière B; Bonduelle O; Iga M; Gao JL; Maho M; Boissonnas A; Murphy PM; Debré P; Combadière C Cancer Res; 2003 Nov; 63(21):7468-74. PubMed ID: 14612547 [TBL] [Abstract][Full Text] [Related]
20. Increased expression of the chemokine fractalkine in Crohn's disease and association of the fractalkine receptor T280M polymorphism with a fibrostenosing disease Phenotype. Brand S; Hofbauer K; Dambacher J; Schnitzler F; Staudinger T; Pfennig S; Seiderer J; Tillack C; Konrad A; Göke B; Ochsenkühn T; Lohse P Am J Gastroenterol; 2006 Jan; 101(1):99-106. PubMed ID: 16405540 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]